OverviewChartNewsTraderScreen

Citi Knock-Out PGR/  DE000KH6KWU6  /

Frankfurt Zert./CITI
5/10/2024  7:41:07 PM Chg.+0.100 Bid9:59:23 PM Ask- Underlying Strike price Expiration date Option type
11.520EUR +0.88% -
Bid Size: -		 -
Ask Size: -		 Progressive Corporat... 92.2822 - 12/31/2078 Call
GlobeNewswire 6:00 PM Crinetics Presents New Data at ENDO 2024 that Increases Body of Evidence Positioning Once-Daily, Ora...
GlobeNewswire 2:11 PM Molecular Templates, Inc. Provides Interim Update
GlobeNewswire 2:00 PM Denali Therapeutics Announces FDA Has Selected DNL126 (ETV:SGSH) for MPS IIIA (Sanfilippo Syndrome T...
GlobeNewswire 2:00 PM Aquestive Therapeutics Announces Executive Appointments and Builds Commercial Capabilities
GlobeNewswire 2:00 PM aTyr Pharma Announces Nasdaq Stock Ticker Symbol Change from “LIFE” to “ATYR”
GlobeNewswire 2:00 PM Enlivex Receives Regulatory Authorization for the Initiation of a Placebo-Controlled Phase I/II Tria...
GlobeNewswire 1:30 PM Opthea To Present at Clinical Trials at the Summit Meeting
GlobeNewswire 1:30 PM TG Therapeutics to Participate in the Jefferies Global Healthcare Conference
GlobeNewswire 12:00 PM MediciNova Announces Data from Phase 1b/2a Clinical Trial of MN-166 (ibudilast) in Glioblastoma Pati...
GlobeNewswire 5/31 TG Therapeutics Announces Presentations for BRIUMVI® (ublituximab) in Multiple Sclerosis at the 2024...
GlobeNewswire 5/30 Biogen Receives European Commission Approval for QALSODY® (tofersen), the First Therapy to Treat a R...
GlobeNewswire 5/30 4DMT to Present Interim Data from Aerosolized 4D-710 Phase 1/2 AEROW Clinical Trial for Cystic Fibro...
GlobeNewswire 5/30 BlueRock Therapeutics receives FDA Regenerative Medicine Advanced Therapy designation for Parkinson’...
GlobeNewswire 5/29 Spinogenix Announces FDA Clearance of IND Application for SPG302, a Novel Therapy for the Treatment ...
GlobeNewswire 5/28 Vera Therapeutics Receives U.S. FDA Breakthrough Therapy Designation for Atacicept in Immunoglobulin...
GlobeNewswire 5/28 Opthea Completes Enrollment in Pivotal Phase 3 Clinical Program with Sozinibercept in Wet AMD
GlobeNewswire 5/28 TG Therapeutics Announces Schedule of Upcoming Presentations for BRIUMVI® (ublituximab) in Multiple ...
GlobeNewswire 5/25 Vera Therapeutics Presents 72-week eGFR Stabilization and Rapid Hematuria Improvement in Phase 2b OR...
GlobeNewswire 5/24 Sobi Receives US FDA Fast Track Designation for Emapalumab-lzsg being investigated in Macrophage Act...
GlobeNewswire 5/24 BriaCell Doubles Progression-Free-Survival (PFS) and Reports Clinical Benefit Data at ASCO 2024
GlobeNewswire 5/23 Candel Therapeutics Reports Prolonged Overall Survival in Phase 2 Clinical Trial of CAN-2409 for Adv...
GlobeNewswire 5/21 Sana Biotechnology Highlights Publication in Nature Biotechnology of Novel In Vivo Preclinical Data ...
GlobeNewswire 5/20 Avalyn Presents Clinical Data on AP01 for Pulmonary Fibrosis, Including Long-Term Efficacy and Imagi...
TeleTrader 5/20 Yellen says US against tax on billionaires
GlobeNewswire 5/20 APRINOIA Therapeutics Announces Fast Track Designation Granted by U.S. FDA to APN-1607 (florzolotau)...